Form 8-K - Current report:
SEC Accession No. 0001140361-25-009939
Filing Date
2025-03-24
Accepted
2025-03-24 06:02:14
Documents
13
Period of Report
2025-03-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20045827x2_8k.htm   iXBRL 8-K 36185
  Complete submission text file 0001140361-25-009939.txt   178424

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA snti-20250320.xsd EX-101.SCH 3982
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE snti-20250320_lab.xml EX-101.LAB 22690
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snti-20250320_pre.xml EX-101.PRE 16552
16 EXTRACTED XBRL INSTANCE DOCUMENT ny20045827x2_8k_htm.xml XML 4388
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 25762121
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)